Literature DB >> 14671409

Insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1 and postnatal growth in very-low-birth-weight infants.

Eero Kajantie1.   

Abstract

Small preterm infants experience a unique postnatal period characterized by slow growth, inadequate nutrition and growth inhibiting treatments. Many have already been growth-restricted in utero. Studying this period is important when developing growth optimizing strategies for these infants and, in a broader context, as a model of extreme conditions that restrict growth. By following short-term growth of 48 very-low-birth-weight (VLBW; birth weight <1,500 g) infants for 9 postnatal weeks, we found that circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels are low and reflect rigorously measured (knemometry and weight) concurrent growth velocity. Moreover, weight growth velocity is correlated with the ratio of lesser to highly phosphorylated IGFBP-1 but not with absolute IGFBP-1 concentrations. Thus, IGF-I, IGFBP-3 and the phosphorylation status of IGFBP-1 in circulation are likely to be involved in growth regulation during the postnatal period in VLBW infants. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671409     DOI: 10.1159/000074513

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  6 in total

1.  Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation.

Authors:  Alexandra J Umbers; Philippe Boeuf; Caroline Clapham; Danielle I Stanisic; Francesca Baiwog; Ivo Mueller; Peter Siba; Christopher L King; James G Beeson; Jocelyn Glazier; Stephen J Rogerson
Journal:  J Infect Dis       Date:  2011-01-07       Impact factor: 5.226

Review 2.  Leg length, body proportion, and health: a review with a note on beauty.

Authors:  Barry Bogin; Maria Inês Varela-Silva
Journal:  Int J Environ Res Public Health       Date:  2010-03-11       Impact factor: 3.390

Review 3.  Measuring growth hormone and insulin-like growth factor-I in infants: what is normal?

Authors:  Colin Patrick Hawkes; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2013-12

4.  Increased hypothalamic-pituitary-adrenal axis activity and hepatic insulin resistance in low-birth-weight rats.

Authors:  Esben S Buhl; Susanne Neschen; Shin Yonemitsu; Joerg Rossbacher; Dongyan Zhang; Katsutaro Morino; Allan Flyvbjerg; Pascale Perret; Varman Samuel; Jung Kim; Gary W Cline; Kitt Falk Petersen
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-09-25       Impact factor: 4.310

5.  A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants.

Authors:  Chatarina Löfqvist; Aimon Niklasson; Eva Engström; Lena E Friberg; Cecilia Camacho-Hübner; David Ley; Jan Borg; Lois E H Smith; Ann Hellström
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

6.  Functional and complementary phosphorylation state attributes of human insulin-like growth factor-binding protein-1 (IGFBP-1) isoforms resolved by free flow electrophoresis.

Authors:  Mikkel Nissum; Majida Abu Shehab; Ute Sukop; Javad M Khosravi; Robert Wildgruber; Christoph Eckerskorn; Victor K M Han; Madhulika B Gupta
Journal:  Mol Cell Proteomics       Date:  2009-02-03       Impact factor: 5.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.